PMDA drug package insert
バッサルトAII
PMDA OTC drug · 小林薬品工業（株） · package insert Aug 22, 2023
Key facts
| Brand names | バッサルトAII |
|---|---|
| Companies | 製造販売元／小林薬品工業（株） |
| Product type | OTC drug |
| OTC risk class | 第「２」類医薬品 |
| OTC dosage form | 錠剤 |
| OTC effect category | 解熱鎮痛薬 |
| Package insert date | Aug 22, 2023 |
| PMDA document key | 270180_K2308000018 |
| PMDA company code | 270180 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- 1–9 Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: